LENZ in the 13F filings
Lenz Therapeutics Inc · CUSIP 52635N103
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 2 Sep 2026
- latest of these filings; the earliest 13 Aug 2026
- Managers listing it
- 16
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 1 listed it in both
- Shares listed
- 8,806,870
- combined, among listed positions
- Reported value
- $50m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 11 buyers (opened or added shares) and 6 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +1,381,181.
Managers listing LENZ in Q2 2026
16 of 16 holders
Largest increases and reductions, by shares
Increases
- Millennium Management LLCexisting position · 1,508,478 shares now+639,221
- Citadel Advisors LLCnew position · 363,229 shares now+363,229
- Marshall Wace LLPexisting position · 493,099 shares now+332,835
- Squarepoint Ops LLCexisting position · 1,747,096 shares now+240,597
- AQR Capital Management LLCexisting position · 227,732 shares now+87,427
Reductions
- Two Sigma Investments LPexisting position · 285,584 shares now-215,413
- Fidelity (FMR LLC)existing position · 3,558,905 shares now-38,879
- Invesco Ltdexisting position · 13,256 shares now-1,671
New positions and exits
New (2)
Exited (3)
- Susquehanna International Group LLPwas $1.0m
- ExodusPoint Capital Management LPwas $527k
- Freestone Grove Partners LPwas $0
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2024 | 1 | $19m | 1 | 0 |
| Q2 2024 | 1 | $15m | 0 | 0 |
| Q3 2024 | 1 | $21m | 0 | 0 |
| Q4 2024 | 1 | $23m | 0 | 1 |
| Q1 2025 | 1 | $22m | 1 | 0 |
| Q4 2025 | 1 | $3.9m | 16 | 9 |
| Q1 2026 | 1 | $2.2m | 10 | 9 |
| Q2 2026 | 1 | $1.4m | 11 | 6 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
LENZ and GILD →LENZ and AMGN →LENZ and ARGX →Choose a stock to compare with LENZ →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own LENZ, latest filings →Back to the 13F Explorer →